483 Tomas Wharton, MD Feb 2018

483 Tomas Wharton, MD Feb 2018

Richard Lyght FDA$119.00 - Available Now

FDA investigators audited the Tomas Wharton, MD - Miami, FL, United States facility and issued inspectional observations (via FDA 483) on 01 Feb 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 01 Feb 2018
  • Location: Miami, United States
  • FEI: 3013976038
Add To Cart